An evaluation of the effect of an angiotensin-converting enzyme inhibitor on the growth rate of small abdominal aortic aneurysms: a randomised placebo-controlled trial (AARDVARK)
Background: Although data are inconsistent, angiotensin-converting enzyme inhibitors (ACE-Is) have been associated with a reduced incidence of abdominal aortic aneurysm (AAA) rupture in analysis of administrative databases. Objectives: (1) To investigate whether or not the ACE-I perindopril (Coversy...
Main Authors: | Gaia Kiru, Colin Bicknell, Emanuela Falaschetti, Janet Powell, Neil Poulter |
---|---|
Format: | Article |
Language: | English |
Published: |
NIHR Journals Library
2016-07-01
|
Series: | Health Technology Assessment |
Online Access: | https://doi.org/10.3310/hta20590 |
Similar Items
-
Investigating the roles of peripheral and central blood pressure and blood pressure variability on the size and growth rate of AAAs in the AARDVARK trial and the CAVE sub-study
by: Kiru, Gayithri
Published: (2017) -
Deficiency of peroxiredoxin 2 exacerbates angiotensin II-induced abdominal aortic aneurysm
by: Se-Jin Jeong, et al.
Published: (2020-09-01) -
Abdominal Aortic Aneurysm
by: Ken Tillman PhD, RN, et al.
Published: (2013-03-01) -
Abdominal Aortic Aneurysms
by: Andreas Frech, et al.
Published: (2012-04-01) -
General Considerations of Ruptured Abdominal Aortic Aneurysm: Ruptured Abdominal Aortic Aneurysm
by: Chung Won Lee, et al.
Published: (2015-02-01)